Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Eli Lilly (NY: LLY )

925.05 -5.33 (-0.57%)
Streaming Delayed Price Updated: 12:57 PM EDT, Aug 15, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,740,991
Open 936.00
Bid (Size) 924.25 (2)
Ask (Size) 925.32 (2)
Prev. Close 930.38
Today's Range 920.00 - 937.96
52wk Range 516.57 - 966.10
Shares Outstanding N/A
Dividend Yield 0.49%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Biden Administration Targets $6B Savings Through Medicare Drug Price Negotiations
Medicare drug price negotiations, enabled by the Inflation Reduction Act, are set to save the U.S. government $6 billion. 
Via Benzinga
Topics Economy
Exposures Interest Rates
Eli Lilly Unusual Options Activity For August 15
Via Benzinga

Performance

YTD
+56.21%
+56.21%
1 Month
-2.67%
-2.67%
3 Month
+17.54%
+17.54%
6 Month
+22.15%
+22.15%
1 Year
+69.23%
+69.23%

More News

Read More
Prediction: This Company Will Disrupt Eli Lilly and Novo Nordisk in the Weight Loss Market (Hint: It's Not Pfizer)
Via The Motley Fool
Medicare Slashes Merck, Novo, AstraZeneca Drug Prices Up To 79% In IRA Negotiations
Via Investor's Business Daily
3 Biotech Stocks to Buy on the Dip: August 2024
Via InvestorPlace
Here's How Much You Would Have Made Owning Eli Lilly Stock In The Last 10 Years
Via Benzinga
Beyond The Numbers: 25 Analysts Discuss Eli Lilly Stock
Via Benzinga
Don't Promote Copycat Weight-Loss Drugs Amid Improved Supply, Eli Lilly Asks Doctors, FDA Evaluates
Via Benzinga
Exposures Product Safety
Eli Lilly Smashed Estimates Thanks To Unbelievable Demand For Its Diabetes And Weight Loss Blockbusters
Via Benzinga
Up 10% in 1 Day, Is It Too Late to Buy Eli Lilly Stock?
Via The Motley Fool
Being Vain Has Its Benefits. Why Eli Lilly And The 'Me-Conomy' Are Here To Stay.
Via Investor's Business Daily
Prediction: The Next Big Biotech Stock Boom Will Be in Longevity Drugs
Via The Motley Fool
3 Stocks on the Rise After Stellar Q2 Earnings Results
Via InvestorPlace
VOO Vs. VTI: Here Are The Key Differences Between Vanguard US Stock Market ETFs Investors Should Know
Via Benzinga
Topics ETFs
This 1 Piece of Good News for Eli Lilly Is Bad News for Hims & Hers Health Stock
Via The Motley Fool
Why Eli Lilly Stock's Big Jump Last Week Could Be Just the Beginning of Another Huge Run
Via The Motley Fool
Weight Loss Drugs Like Ozempic, Zepbound May Reduce Cancer Risks, Studies Suggest
Via Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
Eli Lilly To Rally Around 15%? Here Are 10 Top Analyst Forecasts For Monday
Via Benzinga
Prediction: Buying Biotech and Pharma Stocks During This Sell-Off Will Be a Smart Move
Via The Motley Fool
This Robinhood Analyst Turns Bullish; Here Are Top 5 Upgrades For Monday
Via Benzinga
Eli Lilly: A Pharmaceutical Juggernaut That Just Crushed Earnings Estimates
Via Talk Markets
A Blood Test Could Detect Early Alzheimer's. That Could Make These 2 Stocks Red-Hot Buys.
Via The Motley Fool
MarketBeat Week in Review – 8/5 - 8/9
Via MarketBeat
Topics Economy
Exposures Economy Interest Rates
3 Stocks to Load-Up On Before Autumn Arrives
Via InvestorPlace
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.